Mr. Kenneth Thompson

Director

Dr. Michael J. Dunphy

Director

Dr. Joseph A. Bauer

Secretary/Treasurer

Dr. Annette M. Sysel

President.

Dr. Weisun Rao, Esq.

Of Counsel

Dr. Annette M. Sysel has over 27 years of experience as both a private practice veterinarian and as a surgeon at the Ontario Veterinary College and the Virginia Maryland Regional College of Veterinary Medicine. She is the author of more than 15 scientific publications and book chapters. Her past research established the method of epidural catheterization for the long-term treatment of hind limb pain in horses, a method which was used in the pain management protocol for 2006 Kentucky Derby winner Barbaro following his catastrophic hind limb fracture in the 2006 Preakness Stakes. In 2012 alone, Dr. Sysel procured grant funding from the American Kennel Club, Winn Feline Foundation and Blue Buffalo Foundation for Cancer Research for NO-Cbl-related research. Several scientific studies were published and a provisional patent was filed as a direct result of this research with the potential to improve cancer diagnostics in companion animals. Dr. Sysel was instrumental in promoting a lab-to-leash program at a local University which resulted in the placement of ten male Beagles to loving homes.  Dr. Sysel has established a solid working relationship with the FDA's Center for Veterinary Medicine. In addition, Dr. Sysel has developed relationships in the biotechnology sector because of her featured presentations in both Buzz of Bio, International Business Forum as well as the Buzz of Bio Investor Forum. Dr. Sysel recently became the American Humane Association HERO Veterinarian. Dr. Sysel is committed to developing a safe and effective treatment for cats and dogs https://www.youtube.com/watch?v=WMGz1TH9au8. ​

Dr. Joseph A. Bauer became one of the youngest Staff Scientists in translational medicine at the Cleveland Clinic's Taussig Cancer Center, where he was responsible for drug design and the development of novel drugs with an emphasis on targeted drug delivery. His fields of specialization include signal transduction pathways, apoptosis, cobalamin chemistry including one-carbon metabolism, molecular biology and the biochemistry of nitric oxide. He has over 25 years of experience in drug discovery and development. Dr. Bauer has received over $5M in grant support from the National Institutes of Health (NIH), the National Cancer Institute (NCI) and various other foundations for research pertaining to NO-Cbl. His work has resulted in three United States Patents and over twenty-five foreign patents. He is an author of more than 100 abstracts and manuscripts. He currently serves as an academic editor for the scientific journal PLoS ONE, and is an invited editorial reviewer for the Journal of the National Cancer Institute. He is also a scientific reviewer for the American Association for Cancer Research journals including Molecular Cancer Therapeutics, Cancer Research and Clinical Cancer Research, and for the journals of the American Chemical Society. Dr. Bauer has served as a grant reviewer for the American Cancer Society Research Project Council, and has been an invited grant reviewer for NIH/NCI. Dr. Bauer recently gave the keynote address at the 2014 Annual Meeting of the Ohio Academy of Sciences. Dr. Bauer also holds a degree in Business Administration from Walsh University. https://www.linkedin.com/in/drjabauer

Google Scholar: https://scholar.google.com/citations?user=xIXo2QsAAAAJ&hl=en

​​
Dr. Michael J. Dunphy is the Vice President of Academic Affairs and Professor of Chemistry at Walsh University. He was the former Director of Clinical Toxicology for Accutox Labs, and the former Director of Analytical Toxicology at the Timken Mercy Medical Center. Dr. Dunphy has over 36 years of experience in chromatography and quantitative sciences, as well as 29 years of experience in bio-analytical research. https://www.walsh.edu/michael-dunphy

Mr. Kenneth Thompson graduated from Bowling Green State University with a Bachelor of Science in Business Administration in 1989.  He is the President/Owner of Midwest Process Controls, Inc., has been in the industrial fluid system industry since 1989 and founded Midwest Process Controls in 2001.  Midwest Process Controls (MPC) has rapidly become a premier supplier of leading edge fluid system component technology from some of the industry's most recognized manufacturers. MPC carries industrial products for instrumentation and small process applications. They handle tubing, piping, hoses, fittings, valves, filters, regulators, steam traps, clamps, tools, maintenance supplies, insulating materials, heat trace tubing, gauges, instruments, and many more products and all types of materials.  In addition to Midwest Process Controls, Ken has served on the Board and is the past president of the Cleveland Industrial Distribution Association (CIDA). http://midwestprocesscontrols.com/

Dr. Weisun Rao is the managing partner at Venture Partner, LLC. Dr. Rao focuses his practice on intellectual property law and business law. He is experienced in developing IP strategies and building and managing IP portfolios for legal and business opportunities in the United States, China and elsewhere in the world. Dr. Rao has experience in the pharmaceutical, biotechnology, nutraceutical, medical device, advanced material and mechanical industries. Weisun is also experienced with due diligence and counter-diligence investigation, negotiating and drafting technology transfer agreements and licensing agreements, and providing patentability, validity, infringement, and freedom-to-operate opinions. Weisun is involved in such business transactions as cross-border mergers and acquisitions. He is particularly experienced in advising non-Chinese clients on legal regulations and business practices in China and advising Chinese businesses interested in entering or expanding in the U.S. market. Weisun’s clients include individuals, large corporations, small or medium enterprises and non-for-profit organizations, from the United States, Asia and the Europe Union.